相似文献
1
Similarity and Differences in Inflammation-Related Characteristics of the Peripheral Immune System of Patients with Parkinson's and Alzheimer's Diseases.
Int J Mol Sci. 2017 Dec 6;18(12):2633. doi: 10.3390/ijms18122633.
2
The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
ACS Chem Neurosci. 2016 May 18;7(5):520-7. doi: 10.1021/acschemneuro.6b00042. Epub 2016 Apr 14.
3
Parkinson's Disease is Accompanied by Intertwined Alterations in Iron Metabolism and Activated Immune-inflammatory and Oxidative Stress Pathways.
CNS Neurol Disord Drug Targets. 2017;16(4):484-491. doi: 10.2174/1871527316666170223161004.
4
Altered NR4A Subfamily Gene Expression Level in Peripheral Blood of Parkinson's and Alzheimer's Disease Patients.
Neurotox Res. 2016 Oct;30(3):338-44. doi: 10.1007/s12640-016-9626-4. Epub 2016 May 9.
5
The Trojan horse - neuroinflammatory impact of T cells in neurodegenerative diseases.
Mol Neurodegener. 2017 Oct 27;12(1):78. doi: 10.1186/s13024-017-0222-8.
6
The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease.
J Neuroimmunol. 2015 Jun 15;283:50-7. doi: 10.1016/j.jneuroim.2015.04.014. Epub 2015 Apr 25.
7
The role of Th17 cells in auto-inflammatory neurological disorders.
Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt B):408-416. doi: 10.1016/j.pnpbp.2017.07.023. Epub 2017 Jul 29.
8
Peripheral chemo-cytokine profiles in Alzheimer's and Parkinson's diseases.
Mini Rev Med Chem. 2009 Sep;9(10):1229-41. doi: 10.2174/138955709789055199.
9
An overview of circulating cell-free microRNAs as putative biomarkers in Alzheimer's and Parkinson's Diseases.
Int J Neurosci. 2017 Jun;127(6):547-558. doi: 10.1080/00207454.2016.1209754. Epub 2016 Jul 20.
10
Serum heme oxygenase-1 levels are increased in Parkinson's disease but not in Alzheimer's disease.
Acta Neurol Scand. 2010 Feb;121(2):136-8. doi: 10.1111/j.1600-0404.2009.01261.x. Epub 2009 Sep 24.
引用本文的文献
1
The Role of Nutraceuticals and Functional Foods in Mitigating Cellular Senescence and Its Related Aspects: A Key Strategy for Delaying or Preventing Aging and Neurodegenerative Disorders.
Nutrients. 2025 May 28;17(11):1837. doi: 10.3390/nu17111837.
2
Inflammatory Markers and Risk of Parkinson's Disease: A Population-Based Analysis.
Parkinsons Dis. 2024 Dec 31;2024:4192853. doi: 10.1155/padi/4192853. eCollection 2024.
3
Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson's disease.
Front Immunol. 2024 Mar 25;15:1349030. doi: 10.3389/fimmu.2024.1349030. eCollection 2024.
4
RT-DOb, a switch gene for the gene pair {Csf1r, Milr1}, can influence the onset of Alzheimer's disease by regulating communication between mast cell and microglia.
PLoS One. 2023 Jul 6;18(7):e0288134. doi: 10.1371/journal.pone.0288134. eCollection 2023.
5
Escalating Bi-Directional Feedback Loops between Proinflammatory Microglia and Mitochondria in Ageing and Post-Diagnosis of Parkinson's Disease.
Antioxidants (Basel). 2023 May 18;12(5):1117. doi: 10.3390/antiox12051117.
6
Novel patients with NHLRC2 variants expand the phenotypic spectrum of FINCA disease.
Front Neurosci. 2023 Apr 27;17:1123327. doi: 10.3389/fnins.2023.1123327. eCollection 2023.
7
Involvement of Abnormal p-α-syn Accumulation and TLR2-Mediated Inflammation of Schwann Cells in Enteric Autonomic Nerve Dysfunction of Parkinson's Disease: an Animal Model Study.
Mol Neurobiol. 2023 Aug;60(8):4738-4752. doi: 10.1007/s12035-023-03345-4. Epub 2023 May 6.
8
Neurological Consequences of Pulmonary Emboli in COVID-19 Patients: A Study of Incidence and Outcomes in the Kingdom of Saudi Arabia.
Brain Sci. 2023 Feb 17;13(2):343. doi: 10.3390/brainsci13020343.
9
Peripheral inflammatory immune response differs among sporadic and familial Parkinson's disease.
NPJ Parkinsons Dis. 2023 Jan 31;9(1):12. doi: 10.1038/s41531-023-00457-5.
10
The Selective Loss of Purkinje Cells Induces Specific Peripheral Immune Alterations.
Front Cell Neurosci. 2021 Nov 30;15:773696. doi: 10.3389/fncel.2021.773696. eCollection 2021.
本文引用的文献
1
Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease.
Science. 2017 Sep 22;357(6357):1255-1261. doi: 10.1126/science.aam9080. Epub 2017 Sep 7.
2
Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration.
Front Cell Neurosci. 2017 Jul 24;11:216. doi: 10.3389/fncel.2017.00216. eCollection 2017.
3
Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications.
Oxid Med Cell Longev. 2017;2017:2525967. doi: 10.1155/2017/2525967. Epub 2017 Jul 12.
4
Synapse-specific effects of IL-1β on long-term potentiation in the mouse hippocampus.
Biomed Res. 2017;38(3):183-188. doi: 10.2220/biomedres.38.183.
5
Parkinson's disease-associated genetic variation is linked to quantitative expression of inflammatory genes.
PLoS One. 2017 Apr 13;12(4):e0175882. doi: 10.1371/journal.pone.0175882. eCollection 2017.
6
Neuroinflammation Induces Neurodegeneration.
J Neurol Neurosurg Spine. 2016;1(1). Epub 2016 Nov 18.
7
Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease: A Systematic Review and Meta-analysis.
JAMA Neurol. 2016 Nov 1;73(11):1316-1324. doi: 10.1001/jamaneurol.2016.2742.
8
The levels of 7,8-dihydrodeoxyguanosine (8-oxoG) and 8-oxoguanine DNA glycosylase 1 (OGG1) - A potential diagnostic biomarkers of Alzheimer's disease.
J Neurol Sci. 2016 Sep 15;368:155-9. doi: 10.1016/j.jns.2016.07.008. Epub 2016 Jul 9.
9
Altered plasma marker of oxidative DNA damage and total antioxidant capacity in patients with Alzheimer's disease.
Caspian J Intern Med. 2016 Spring;7(2):88-92.
10
Neuroinflammation in Alzheimer's disease: Current evidence and future directions.
Alzheimers Dement. 2016 Jun;12(6):719-32. doi: 10.1016/j.jalz.2016.02.010. Epub 2016 May 11.
Zotero 插件